Patents Assigned to Epivax, Inc.
  • Regulatory T cell epitopes
    Patent number: 11911414
    Abstract: The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprises a polypeptide comprising at least a portion of SEQ NOS: 1-124 (and/or fragments and variants thereof), and optionally 1 to 12 additional amino acids distributed in any ratio on the N-terminus and/or C-terminus of the polypeptide of SEQ ID NOS: 1-124, as well as methods of producing and using the same.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: February 27, 2024
    Assignee: EpiVax Inc.
    Inventors: Anne De Groot, William Martin
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11844826
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: April 21, 2021
    Date of Patent: December 19, 2023
    Assignee: EpiVax Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • epitopes for T cell-targeted Q fever vaccines
    Patent number: 11690902
    Abstract: Compositions and methods for inducing a protective immune response against Coxiella burnetii, to reduce a subject's risk of developing Q fever.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: July 4, 2023
    Assignees: The General Hospital Corporation, EpiVax, Inc., Innatoss Laboratories B.V.
    Inventors: Mark C. Poznansky, Ann Elizabeth Sluder, Timothy Alan Brauns, Anne Searls De Groot, Leonard Jeffrey Moise, Anja Garritsen, Anja Scholzen
  • Regulatory T cell epitopes
    Patent number: 11441122
    Abstract: The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprise a polypeptide comprising at least a portion of SEQ NOS: 1-14, fragments and/or variants thereof, as well as methods of producing and using the same.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: September 13, 2022
    Assignees: EpiVax Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services Food and Drug Administration
    Inventors: William Martin, Amy S. Rosenberg
  • PEPTIDES FOR INDUCING HETEROSUBTYPIC INFLUENZA T CELL RESPONSES
    Publication number: 20210380644
    Abstract: The present invention provides compositions and methods for generation of an anti-influenza immune response. In particular, conserved T cell epitopes within matrix protein and nucleoprotein components of influenza virus have been identified and further screened for those structures that will bind either or both of HLA I and II molecules. Methods for vaccinating subjects with formulations of such peptides for the treatment or prevention of influenza infection also are described.
    Type: Application
    Filed: October 25, 2019
    Publication date: December 9, 2021
    Applicants: Saint Louis University, EpiVax, Inc.
    Inventors: Daniel F. HOFT, Christopher S. EICKHOFF, Annie DE GROOT
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045530
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045532
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045529
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045531
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 11045528
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: June 29, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10980867
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: April 20, 2021
    Assignee: EpiVax Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925940
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925941
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: October 16, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925942
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10925939
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: February 23, 2021
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • Peptides for inducing Chagas disease responses
    Patent number: 10821164
    Abstract: The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
    Type: Grant
    Filed: June 6, 2016
    Date of Patent: November 3, 2020
    Assignees: Saint Louis University, EPIVAX, INC.
    Inventors: Daniel Hoft, Chris Eickhoff, Annie De Groot
  • Regulatory T cell epitopes, compositions and uses thereof
    Patent number: 10751397
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Grant
    Filed: June 22, 2018
    Date of Patent: August 25, 2020
    Assignee: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190351036
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: August 2, 2019
    Publication date: November 21, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190183994
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 20, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera
  • REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
    Publication number: 20190183993
    Abstract: The invention is directed to T cell epitopes wherein said epitopes comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region. The invention also relates to methods of using and methods of making the epitopes of the invention.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 20, 2019
    Applicant: EpiVax, Inc.
    Inventors: Anne De Groot, William Martin, Daniel S. Rivera